PHARMA-TECH A/S: Financial statements 2025
CVR: 32940897
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PHARMA-TECH A/S (CVR 32940897) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 32,243,339 and a net result of DKK 5,636,893 compared with DKK 6,599,234 the year before. That is an increase of 16.2% compared with the year before. Equity in the 2025 report amounted to DKK 24,456,581. The solvency ratio was 53.3%. The company had 32 employees in the financial year.
- Gross Profit
- DKK 32,243,339
- Profit/Loss
- DKK 5,636,893
- Equity
- DKK 24,456,581
- Total Assets
- DKK 45,921,701
- Employees
- 32
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 32.2 mio. | 5.6 mio. | 24.5 mio. | 32 |
| 2024 | - | 27.7 mio. | 6.6 mio. | 22.8 mio. | 25 |
| 2023 | - | 24.1 mio. | 6.5 mio. | 24.2 mio. | 23 |
| 2022 | - | 19.3 mio. | 4.3 mio. | 19.8 mio. | 21 |
| 2021 | - | 18 mio. | 3.1 mio. | 17.4 mio. | 21 |
Official annual report
How creditworthy is PHARMA-TECH A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 4, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of PHARMA-TECH A/S.
As of September 4, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of PHARMA-TECH A/S.
PHARMA-TECH A/S has published its annual report for 2024. Gross profit came to DKK 27,739,337, and the net result was DKK 6,599,234.
About PHARMA-TECH A/S
PHARMA-TECH A/S is a Danish company of the type Aktieselskab based in Randers SV, founded in 2010. The company is registered under the industry Fremstilling af plastemballage. The management consists of Morten Hart Johansen. The board consists of Claus Wædeled (chair), Morten Hart Johansen and Rikke Winther. The company is owned by JoWin Holding ApS. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 32,243,339 and a net result of DKK 5,636,893 compared with DKK 6,599,234 the year before. Equity in the 2025 report amounted to DKK 24,456,581.